CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home »

ONCOLOGY. Vol. 9 No. 6
 

Indicators of Nicotine Addiction Among Women-United States, 1991 to 1992

June 1, 1995

An estimated 22 million US women were current smokers in 1993; of these, 73% wanted to quit smoking [1]. However, attempts to quit smoking and to remain abstinent are hindered by nicotine(Drug information on nicotine) addiction and by the subsequent effects of nicotine withdrawal [2]. To assess the prevalence of selected indicators of nicotine addiction among U.S. women, Centers for Disease Control (CDC) analyzed data from the National Household Survey on Drug Abuse (NHSDA) in 1991 and 1992 [3]. This report presents the findings of the analysis.

The NHSDA is a household survey of a nationally representative sample of the civilian, noninstitutionalized U.S. population. Combined data from the 1991 and 1992 surveys (n = 7,137) were used to estimate the prevalences of four indicators of nicotine addiction among women who smoke. Information about these indicators was based on responses to four questions; current smokers (defined as persons who had ever smoked 100 cigarettes and had smoked during the 30 days preceding the survey) were asked whether, during the 12 months preceding the survey, they:

1. Felt they needed or were dependent on cigarettes

2. Needed larger amounts (more cigarettes) to get the same effect

3. Felt unable to cut down on their use even though they tried

4. Had withdrawal symptoms, that is, felt sick because they stopped or cut down on cigarette use.

The analysis of "unable to cut down" (n = 4,422) and "felt sick" (n = 4,646) was restricted to persons who reported trying to reduce their use of cigarettes during the preceding 12 months. In addition, for the indicator "unable to cut down," because of the question design, respondents who reported not trying to reduce any drug use during the preceding 12 months (n = 224) also were excluded. Because the likelihood of daily smoking and the intensity of smoking (ie, number of cigarettes smoked per day) varies directly with age, respondents were classified into two age groups: 12- to 24-year-olds and 25-year-olds and older.

Among female smokers in both age groups, 75% reported feeling dependent on cigarettes. The prevalence of feeling dependent varied directly with intensity of smoking; among those who smoked 6 to 15 cigarettes per day, 80.6% of those aged 12 to 24 years, and 76.1% of those aged 25 years and older reported feeling dependent on cigarettes. Female smokers aged 12 to 24 years were more likely to report needing more cigarettes to attain the same effect than were those aged 25 years and older (18.0% vs 13.2%). Among those who had tried to reduce smoking during the preceding 12 months, 81.5% of 12- to 24-year-olds, and 77.8% of 25-year-olds and older reported being unable to do so. Even among those who smoked 6 to 15 cigarettes per day, inability to reduce smoking was reported by 82.6% of 12- to 24-year-olds, and 73.8% of the 25-year-olds and older. Of all female smokers aged 12 years and older, 35.4% reported withdrawal symptoms (ie, feeling sick) when they tried to reduce their smoking.

Females in both the younger and older age groups were equally likely to report at least one of the four indicators of nicotine addiction (81.2% and 79.4%, respectively). Even among females who smoked five or fewer cigarettes per day, 63.1% of those aged 12 to 24 years, and 53% of those aged 25 years and older reported one or more of these indicators.

Editorial Note from the CDC: In 1990, an estimated 61,000 U.S. women aged 35 years and older died from cardiovascular diseases attributable to cigarette smoking [4]. Because the risk for myocardial infarction can be reduced by 50% after 1 year of abstaining from smoking, [5] interventions to encourage smoking cessation are an important strategy to reduce cardiovascular mortality. Although most women smokers want to quit smoking, only 2.5% of all smokers successfully quit each year [6]. The finding in this report that approximately 80% of female smokers reported symptoms of nicotine addiction underscores the importance of measures to increase women's access to cessation interventions, including adjunctive nicotine-replacement therapy.

The findings in this report are subject to at least two limitations:

First, the NHSDA indicators are not comprehensive measures of nicotine addiction, and do not include all symptoms of nicotine withdrawal (eg, anxiety, irritability, anger, difficulty concentrating, hunger, or cravings for cigarettes)2; as a result, the NHSDA data may underestimate the proportion of smokers who report at least one indicator of nicotine addiction.

Second, these findings are based on self-reported data, and perceptions of nicotine addiction were not validated. However, in previous studies, self-reported symptoms of nicotine addiction have been confirmed by observer rating [2].

Although manifestations of cardiovascular disease occur primarily during adulthood, related high-risk behaviors, such as tobacco use, often are initiated during adolescence; an estimated 87% of female daily smokers began smoking at 18 years or younger of age (CDC, unpublished data, 1991). Young persons often try using tobacco with a belief that they can quit. However, of adolescent smokers who have intended to not be smoking in 5 to 6 years, 73% still smoked 5 years later [7]. The 1991 and 1992 NHSDA data suggest that an important reason for young smokers' failure to quit smoking is a prevalence of addiction similar to that among older smokers. Because of the difficulty in achieving abstinence, and the strength and early onset of nicotine addiction, interventions to prevent smoking initiation are important.

School-based programs, combined with community interventions, have been effective in preventing smoking initiation [7]. Other measures that can prevent smoking initiation, onset of nicotine addiction, and subsequent morbidity and mortality associated with cardiovascular diseases include enforcement of laws that prohibit sales to minors, counteradvertising campaigns that "deglamorize" smoking to youth, and increases in the real price of cigarettes.

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.





1. CDC: Cigarette smoking among adults-United States, 1993. MMWR 43:925-930, 1994.

2. CDC: The health consequences of smoking: Nicotine addiction-A report of the Surgeon General. Rockville, Maryland, US Department of Health and Human Services, Public Health Service, CDC, DHHS publ (CDC)88-8406, 1988.

3. Substance Abuse and Mental Health Services Administration: National household survey on drug abuse: Population estimates, 1992. Rockville, Maryland, US Department of Health and Human Services, Public Health Service, Substance Abuse and Mental Health Services Administration, DHHS publ (SMA)93-2053, 1993.

4. CDC: Cigarette smoking-Attributable mortality and years of potential life lost-United States, 1990. MMWR 42:645-649, 1993.

5. CDC: The health benefits of smoking cessation: A report of the Surgeon General, 1990. Rockville, Maryland, US Department of Health and Human Services, Public Health Service, DHHS publ (CDC)90-8416, 1990.

6. CDC: Smoking cessation during previous year among adults-United States, 1990 and 1991. MMWR 42:504-507, 1993.

7. US Department of Health and Human Services: Preventing tobacco use among young people: A report of the Surgeon General. Atlanta, US Department of Health and Human Services, Public Health Service, CDC, National Center for Chronic Disease Prevention and Health


 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
IMAGE IQ

Lower Back Pain in an Elderly Man With a History of Localized Prostate Cancer
James B. Yu, MD1 , May 17, 2013

A 70-year-old man with a history of localized prostate cancer treated with whole-pelvis radiation therapy with a boost to the prostate, in conjunction with androgen deprivation therapy 7 years prior, presented with lower back pain. A bone scan revealed an area of activity in the sacrum. What is the most likely diagnosis?

More Image IQs 

 
FROM PHYSICIANS PRACTICE
Primary Care Can't Thrive Without Nurse Practitioners
Courtney H. Lyder, ND,  May 17, 2013
With a projected shortfall of primary-care physicians, it's time for alternate solutions to patient care. Nurse practitioners are one logical remedy.
VWhat Physicians Can Learn from the Allscripts EHR Lawsuit
Marisa Torrieri,  May 16, 2013
Lawsuit prompts question: What should physicians do to ensure they end up with a great EHR instead of buyer’s remorse?
Eight Ways ICD-9 Will Still Matter to Medical Practices
Brenda Edwards, CPC,  May 15, 2013
What should your medical practice do with your ICD-9-CM book after October 1, 2014? Keep it.
Seven Ways Technology Can Speed Up Patient Collections
Cheyenne Brinson,  May 15, 2013
Failing to adopt widely available billing and collections technology can cost medical practices big. Here's how to do it right.
Four Reasons Private Medical Practice is Becoming Extinct
Carol Stryker,  May 15, 2013
It’s becoming increasingly difficult for private medical practices to thrive. Here’s what’s driving the trend toward consolidation.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Colorectal Lesions
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Skin Lesions
  • Slide Show: Squamous Cell Carcinoma of the Head and Neck
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Colorectal Lesions
  • ONS: Understanding Spirituality and How It Can Be Used to Help Patients
  • New AUA Guidelines for Prostate Cancer Screening
  • 50 Shades of Pink—And Why It Helps to Know the Difference
  • Genomics Studies Identify Testicular Cancer Risk Variants
  • Lower Back Pain in an Elderly Man With a History of Localized Prostate Cancer
  • FDA Approves Erlotinib (Tarceva) as First-Line Lung Cancer Therapy for Certain Patients
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • “This Is My Last Day on Earth”
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
  • Patient Quality of Life Endpoints in Oncology Trials, Part II
  • Who's Coding Whom?
  • “How Do I Say This Nicely? Your Oncologist Wasn't Following Guidelines”
  • Cancer Metabolism as a Therapeutic Target
  • Study: Cholesterol Drugs Reduced Risk of Prostate Cancer Death
  • “This Is My Last Day on Earth”
  • ONS: Safe Handling of Chemotherapy
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
Click here to subscribe to our newsletter



CancerNetwork on Facebook

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy